title: [Borderline tumors of the ovary: a multicenter study in 137 patients].
abstract: OBJECTIVE
  Evaluate management of patients with a borderline ovarian tumor.
  
  
  METHODS
  A multicentric retrospective survey was conducted in 137 patients with borderline ovarian tumor diagnosed between January 1, 19975 and December 31, 1995.
  
  
  RESULTS
  Mean follow-up was 6.5 years, mean age was 50 years. Initial surgery was cystectomy, unilateral salpingo-oophorectomy and total hysterectomy with bilateral salpingo-oophorectomy in 22, 40 and 75 cases respectively. Eleven patients had residual disease. Serous, mucinous and Brenner tumors were observed in 67, 69 and 1 cases respectively. Staging was I, II, III in 117, 3, and 17 cases respectively with two pseudomyxomas. Adjuvant therapy was given in 15 patients. There was a recurrence in 15 patients and 14 died. The 5-year survival rate was 89.3%. Prognosis factors with an impact on survival rate were age, recurrence and type of surgery. Factors with a negative impact on recurrence were adjuvant therapy and residual disease after surgery.
  
  
  CONCLUSIONS
  Careful staging followed by complete and radical surgery is essential. Unilateral salpingo-oophorectomy with omentectomy and multiple peritoneal biopsies may be indicated in younger patients undergoing radical surgery after pregnancy. Aduvant therapy is necessary for invasive implants.
authors.affiliation: Clinique Gynécologique et Obstétrique Universitaire du Beffroi, 23, avenue de Roubaix, 37044 Tours Cedex 1.
authors.forename: L
authors.initials: L
authors.lastname: Bonnamy
authors.forename: A
authors.initials: A
authors.lastname: Fignon
authors.forename: F
authors.initials: F
authors.lastname: Fetissof
authors.forename: C
authors.initials: C
authors.lastname: Berger
authors.forename: G
authors.initials: G
authors.lastname: Body
authors.forename: J
authors.initials: J
authors.lastname: Lansac
mesh_terms: D001706:Biopsy; D003131:Combined Modality Therapy; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009852:Omentum / Q000601:surgery; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D010052:Ovariectomy; D010537:Peritoneum / Q000473:pathology; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate